Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MarketLine (a Datamonitor Company)
$175.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AstraZeneca PLC Buys Early-Stage U.S. Biotech Firm-Reuters


Wednesday, 3 Apr 2013 06:45am EDT 

Reuters reported that AstraZeneca PLC has bought privately held U.S. biotechnology company AlphaCore Pharma, which is developing a new type of cholesterol medicine. Financial details of the acquisition by the British drugmaker's MedImmune unit were not disclosed. 

Company Quote

73.91
0.25 +0.34%
26 Nov 2014